W. R. Heath and F. R. Carbone, Cross-presentation, dendritic cells, tolerance and immunity, Annu Rev Immunol, vol.19, pp.47-64, 2001.

M. Uhl, O. Kepp, and H. Jusforgues-saklani, Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virusspecific CD81 T cells, Cell Death Differ, vol.16, pp.991-1005, 2009.

L. A. Harshyne, S. C. Watkins, and A. Gambotto, Dendritic cells acquire antigens from live cells for cross-presentation to CTL, J Immunol, vol.166, pp.3717-3740, 2001.

C. Maranon, J. F. Desoutter, and G. Hoeffel, Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD41 T lymphocytes, Proc Natl Acad Sci, vol.101, pp.6092-6099, 2004.

D. Matheoud, C. Baey, and L. Vimeux, Dendritic cells crosspresent antigens from live B16 cells more efficiently than from apoptotic cells and protect from melanoma in a therapeutic model, PLoS One, vol.6, p.19104, 2011.

K. Shortman and W. R. Heath, The CD81 dendritic cell subset, Immunol Rev, vol.234, pp.18-31, 2010.

K. Hildner, B. T. Edelson, and W. E. Purtha, Batf3 deficiency reveals a critical role for CD8alpha1 dendritic cells in cytotoxic, T cell immunity. Science, vol.322, pp.1097-100, 2008.

A. Bachem, S. Guttler, and E. Hartung, Superior antigen cross-presentation and XCR1 expression define human CD11c1CD1411 cells as homologues of mouse CD81 dendritic cells, J Exp Med, vol.207, pp.1273-81, 2010.

M. Haniffa, A. Shin, and V. Bigley, Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD1031 nonlymphoid dendritic cells, Immunity, vol.37, pp.60-73, 2012.

K. Crozat, R. Guiton, and V. Contreras, The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha1 dendritic cells, J Exp Med, vol.207, pp.1283-92, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00493468

S. L. Jongbloed, A. J. Kassianos, and K. J. Mcdonald, BDCA-3)1 dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens, J Exp Med, vol.207, pp.1247-60, 1411.

L. F. Poulin, M. Salio, and E. Griessinger, Characterization of human DNGR-11 BDCA31 leukocytes as putative equivalents of mouse CD8alpha1 dendritic cells, J Exp Med, vol.207, pp.1261-71, 2010.

L. Cohn, B. Chatterjee, and F. Esselborn, Antigen delivery to early endosomes eliminates the superiority of human blood BDCA31 dendritic cells at cross presentation, J Exp Med, vol.210, pp.1049-63, 2013.

E. Segura, M. Durand, and S. Amigorena, Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells, J Exp Med, vol.210, pp.1035-1082, 2013.

F. Gerosa, B. Baldani-guerra, and C. Nisii, Reciprocal activating interaction between natural killer cells and dendritic cells, J Exp Med, vol.195, pp.327-360, 2002.

R. M. Srivastava, S. C. Lee, A. Filho, and P. A. , Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients, Clin Cancer Res, vol.19, pp.1858-72, 2013.

S. Agaugue, E. Marcenaro, and B. Ferranti, Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells, Blood, vol.112, pp.1776-83, 2008.

D. Piccioli, S. Sbrana, and E. Melandri, Contactdependent stimulation and inhibition of dendritic cells by natural killer cells, J Exp Med, vol.195, pp.335-376, 2002.

F. Tanaka, W. Hashimoto, and H. Okamura, Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells, Cancer Res, vol.60, pp.4838-4882, 2000.

T. Dao, M. Gomez-nunez, and C. Antczak, Natural killer cells license dendritic cell crosspresentation of B lymphoma cell-associated antigens, Clin Cancer Res, vol.11, pp.8763-72, 2005.

R. B. Mailliard, Y. I. Son, and R. Redlinger, Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function, J Immunol, vol.171, pp.2366-73, 2003.

C. Retiere, V. Prod'homme, and B. M. Imbert-marcille, Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response, J Virol, vol.74, pp.3948-52, 2000.

J. B. Guillerme, N. Boisgerault, and D. Roulois, Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells, Clin Cancer Res, vol.19, pp.1147-58, 2013.

B. A. Rabinovich, J. Li, and J. Shannon, Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells, J Immunol, vol.170, pp.3572-3578, 2003.

P. Castiglioni, A. Martin-fontecha, and G. Milan, Apoptosis-dependent subversion of the Tlymphocyte epitope hierarchy in lymphoma cells, Cancer Res, vol.62, pp.1116-1138, 2002.

N. Labarriere, L. Bretaudeau, and N. Gervois, Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A/MART-1 antigen, Int J Cancer, vol.101, pp.280-286, 2002.
URL : https://hal.archives-ouvertes.fr/inserm-02482082

M. M. Menager, G. Menasche, and M. Romao, Secretory cytotoxic granule maturation and exocytosis require the effector protein hMunc13-4, Nat Immunol, vol.8, pp.257-67, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-02440339

T. Walzer, M. Dalod, and S. H. Robbins, Naturalkiller cells and dendritic cells: "l'union fait la force, Blood, vol.106, pp.2252-2260, 2005.

D. Matheoud, L. Perie, and G. Hoeffel, Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo, Blood, vol.115, pp.4412-4432, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00493469

B. Strehl, U. Seifert, and E. Kruger, Interferongamma, the functional plasticity of the ubiquitinproteasome system, and MHC class I antigen processing, Immunol Rev, vol.207, pp.19-30, 2005.

F. Saccheri, C. Pozzi, and F. Avogadri, Bacteriainduced gap junctions in tumors favor antigen cross-presentation and antitumor immunity, Sci Transl Med, vol.2, pp.44-57, 2010.

M. A. Bausero, R. Gastpar, and G. Multhoff, Alternative mechanism by which IFN-gamma enhances tumor recognition: active release of heat shock protein 72, J Immunol, vol.175, pp.2900-2912, 2005.

J. Wolfers, A. Lozier, and G. Raposo, Tumorderived exosomes are a source of shared tumor rejection antigens for CTL cross-priming, Nat Med, vol.7, pp.297-303, 2001.

C. Semino, J. Ceccarelli, and L. V. Lotti, The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion, J Leukoc Biol, vol.81, pp.92-101, 2007.

M. Vitale, C. M. Della, and S. Carlomagno, NKdependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor, Blood, vol.106, pp.566-71, 2005.

E. Segura, J. Valladeau-guilemond, and M. H. Donnadieu, Characterization of resident and migratory dendritic cells in human lymph nodes, J Exp Med, vol.209, pp.653-60, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00723792

M. P. Chao, I. L. Weissman, and R. Majeti, The CD47-SIRPalpha pathway in cancer immune evasion and potential therapeutic implications, Curr Opin Immunol, vol.24, pp.225-257, 2012.

I. Perrot, F. Deauvieau, and C. Massacrier, TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA, J Immunol, vol.185, pp.2080-2088, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00553598

S. H. Robbins, T. Walzer, and D. Dembele, Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling, Genome Biol, vol.9, p.17, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00282558

B. G. Dorner, M. B. Dorner, and X. Zhou, Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD81 T cells, Immunity, vol.31, pp.823-856, 2009.

P. Krebs, M. J. Barnes, and K. Lampe, NK-cellmediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses, Blood, vol.113, pp.6593-602, 2009.

C. Adam, S. King, and T. Allgeier, DC-NK cell cross talk as a novel CD41 T-cell-independent pathway for antitumor CTL induction, Blood, vol.106, pp.338-382, 2005.

R. Mocikat, H. Braumuller, and A. Gumy, Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses, Immunity, vol.19, pp.561-570, 2003.

C. Liu, Y. Lou, and G. Lizee, Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice, J Clin Invest, vol.118, pp.1165-75, 2008.

S. Dall'ozzo, S. Tartas, and G. Paintaud, Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship, Cancer Res, vol.64, pp.4664-4673, 2004.

S. Park, Z. Jiang, and E. D. Mortenson, The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity, Cancer Cell, vol.18, pp.160-70, 2010.

R. Nasser, M. Pelegrin, and H. A. Michaud, Longlasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody, J Virol, vol.84, pp.10169-81, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02193587

R. Abes, E. Gelize, and W. H. Fridman, Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response, Blood, vol.116, pp.926-960, 2010.

J. A. Westwood, J. M. Kelly, and J. E. Tanner, Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD41 T cell pathway, J Immunol, vol.172, pp.757-61, 2004.